BrainAurora Medical Technology (HKG:6681) launched its HK$583.2 million initial public offering in Hong Kong on Monday.
The digital diagnostics and therapies provider is offering 181,112,000 shares at HK$3.22 apiece.
BrainAurora secured four cornerstone investors, including Tasly Pharmaceuticals (SHA:600535), which committed to subscribe to $48.5 million worth of IPO shares.
The issuer expects to disclose the allocations on Jan. 7. It will start trading on the Hong Kong bourse on Jan. 8, according to a Monday filing.
Deal proceeds will be used for research and development, clinical trials, technology upgrades, new cognitive centers, and working capital.
CICC, SPDB International, CMBC International, Fosun International, GF Securities, and several others are the joint book-runners of the IPO.
Comments